EANS-DD: AGENNIX AG / Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG

--------------------------------------------------------------------------------
Notification concerning transactions by persons discharging managerial
responsibilities pursuant to section 15a of the WpHG, transmitted by euro
adhoc with the aim of a Europe-wide distribution. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------

Details of the person subject to the disclosure requirement:
--------------------------------------------------------------------------------

Person, triggering the disclosure:
-----------------------------
Name: dievini Hopp BioTech holding GmbH & Co. KG
(Legal person, company or institution)

Reason for the disclosure requirement:
------------------------------
Reason: Legal person, company or institution closely associated
Relationship: To a person performing managerial responsibilities

Person performing managerial responsibilities, triggering the disclosure
requirement:

--------------------------------------------------------------------------------
Position: Member of an administrative or supervisory body

Details of the transaction:
--------------------------------------------------------------------------------

Transaction:
------------
Description of financial instrument: Ordinary bearer shares with no par value
ISIN: DE000A1A6XX4
Type of transaction: sales
Date: 26.11.2010
Currency: Euro
Price: 3.81000
No of items: 688112
Total amount traded: 2,621,706.72000
Place: OTC
Explanation: The shares were sold to an indirect parent company of
dievini BioTech holding GmbH & Co. KG, that also previously
held shares in Agennix AG. The sale by dievini Hopp BioTech
holding GmbH & Co. KG is attributed to the named members of
the managing and supervisoring bodies (Prof. von Bohlen und
Halbach as a member of the Management Board and Prof.
Hettich as a member of the Supervisory Board).

Further inquiry note:
-----------------
Investor Relations & Corporate Communications
Tel.: +49 (0) 89 8565 2693
E-Mail: ir@agennix.com

Issuer subject to the publication requirement:
--------------------------------------------------------------------------------

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: AGENNIX AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Branche: Pharmaceuticals
ISIN: DE000A1A6XX4
WKN: A1A6XX
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade